SEC Form D private-offering filing

Verismo Therapeutics, Inc.

Name: Verismo Therapeutics, Inc. - new SEC Form D private-offering filing, Philadelphia, PA
Published: 2026-05-20

A new SEC Form D private-offering notice from Philadelphia, PA, a $28,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Verismo Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical-stage biotech developing KIR-CAR T cell therapies for solid tumors and blood cancers, founded by Penn Medicine researchers who helped invent Kymriah.

Filed 2026-05-20Filed to raise $28,000,000First money in 2026-04-21Raised so far $28,000,000HQ (as filed) Philadelphia, PASector Biotech ✓Stage (inferred) GrowthCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified verismotherapeutics.com↗Named in the filing 5 executives & directors

Open this row on the live feed →More new filings in Pennsylvania →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.